{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Dercle L"],"funding":["NCI NIH HHS"],"pagination":["1-8"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC6874047"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["1"],"pubmed_abstract":["Purpose
New response patterns to anticancer drugs have led tumor size-based response criteria to shift to also include density measurements. Choi criteria, for instance, categorize antiangiogenic therapy response as a decrease in tumor density > 15% at the portal venous phase (PVP). We studied the effect that PVP timing has on measurement of the density of liver metastases (LM) from colorectal cancer (CRC).Methods
Pretreatment PVP computed tomography images from 291 patients with LM-CRC from the CRYSTAL trial (Cetuximab Combined With Irinotecan in First-Line Therapy for Metastatic Colorectal Cancer; ClinicalTrials.gov identifier: NCT00154102) were included. Four radiologists independently scored the scans' timing according to a three-point scoring system: early, optimal, la"],"journal":["JCO clinical cancer informatics"],"pubmed_title":["Impact of Variability in Portal Venous Phase Acquisition Timing in Tumor Density Measurement and Treatment Response Assessment: Metastatic Colorectal Cancer as a Paradigm."],"pmcid":["PMC6874047"],"funding_grant_id":["U01 CA140207"],"pubmed_authors":["Yang H","Lu L","Piessevaux H","Schwartz LH","Dercle L","Zhu J","Zhao B","Lichtenstein P","Wang D","Wu F"],"additional_accession":[]},"is_claimable":false,"name":"Impact of Variability in Portal Venous Phase Acquisition Timing in Tumor Density Measurement and Treatment Response Assessment: Metastatic Colorectal Cancer as a Paradigm.","description":"Purpose
New response patterns to anticancer drugs have led tumor size-based response criteria to shift to also include density measurements. Choi criteria, for instance, categorize antiangiogenic therapy response as a decrease in tumor density > 15% at the portal venous phase (PVP). We studied the effect that PVP timing has on measurement of the density of liver metastases (LM) from colorectal cancer (CRC).Methods
Pretreatment PVP computed tomography images from 291 patients with LM-CRC from the CRYSTAL trial (Cetuximab Combined With Irinotecan in First-Line Therapy for Metastatic Colorectal Cancer; ClinicalTrials.gov identifier: NCT00154102) were included. Four radiologists independently scored the scans' timing according to a three-point scoring system: early, optimal, la","dates":{"release":"2017-01-01T00:00:00Z","publication":"2017 Nov","modification":"2025-04-04T03:27:08.899Z","creation":"2020-05-21T21:10:03Z"},"accession":"S-EPMC6874047","cross_references":{"pubmed":["30657405"],"doi":["10.1200/cci.17.00108","10.1200/CCI.17.00108"]}}